Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma

BACKGROUND: BCL2L13 belongs to the BCL2 super family, with its protein product exhibits capacity of apoptosis-mediating in diversified cell lines. Previous studies have shown that BCL2L13 has functional consequence in several tumor types, including ALL and GBM, however, its function in kidney cancer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell Int
Main Authors: Meng, Fei, Zhang, Luojin, Zhang, Mingjun, Ye, Kaiqin, Guo, Wei, Liu, Yu, Yang, Wulin, Zhai, Zhimin, Wang, Hongzhi, Xiao, Jun, Dai, Haiming
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Primary Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247248/
https://ncbi.nlm.nih.gov/pubmed/34193180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-02039-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados